Molina Healthcare adds $500 million term loan to partly fund stock buyback
Molina Healthcare entered a Fourth Amendment to its credit agreement with Truist Bank as administrative agent, adding a $500 million Delayed Draw A-2 term loan maturing August 12, 2027. The company said it intends to use the proceeds to partially fund its previously authorized stock repurchase program, as a temporary measure tied to the timing of subsidiary dividends to the parent later this year.
Key points
- New Delayed Draw A-2 commitment totals $500 million, maturing August 12, 2027
- Loans carry an applicable margin of 0.50% for base rate loans and 1.50% for SOFR-based loans
- Proceeds intended to partially fund the previously authorized stock repurchase program
- Terms otherwise substantially similar to the prior credit agreement dated June 8, 2020
The filing
Written by AI on Nov 8, 2026, 12:56 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 12, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.